{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:35:08Z","timestamp":1794069308844,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vascn.2021.107085","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T03:27:15Z","timestamp":1624678035000},"page":"107085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Differentiating multichannel block on the guinea pig ECG: Use of Tpeak-Tend and J-Tpeak"],"prefix":"10.1016","volume":"111","author":[{"given":"Matt","family":"Skinner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ceuppens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vascn.2021.107085_bb0005","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.vascn.2021.107085_bb0010","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.hrthm.2007.05.028","article-title":"Does Tpeak-Tend provide an index of transmural dispersion of repolarization?","volume":"4","author":"Antzelevitch","year":"2007","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.vascn.2021.107085_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00210-001-0490-1","article-title":"Inhibition of cardiac potassium currents by pentobarbital","volume":"365","author":"Bachmann","year":"2002","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107085_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1091581818813601","article-title":"A proof-of-concept evaluation of JTPc and Tp-Tec as Proarrhythmia biomarkers in preclinical species: A retrospective analysis by an HESI-sponsored consortium","volume":"38","author":"Boulay","year":"2019","journal-title":"International Journal of Toxicology"},{"issue":"3","key":"10.1016\/j.vascn.2021.107085_bb0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1472-8206.1995.tb00291.x","article-title":"Proarrhythmic effects of a quinidine analog in dogs with chronic A-V block","volume":"9","author":"Ch\u00e9zalviel-Guilbert","year":"1995","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2021.107085_bb0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"4","key":"10.1016\/j.vascn.2021.107085_bb0035","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00005344-198710000-00016","article-title":"Effect of sodium pentobarbital on the transmembrane action potential and the slow inward current of guinea pig ventricular myocytes","volume":"10","author":"Gilat","year":"1987","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2021.107085_bb0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1476-5381.2011.01795.x","article-title":"The electro-mechanical window in anaesthetized guinea pigs: A new marker in screening for Torsade de Pointes risk","volume":"166","author":"Guns","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2021.107085_bb0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/toxsci\/kfg254","article-title":"QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles","volume":"76","author":"Hamlin","year":"2003","journal-title":"Toxicological Sciences: An Official Journal of the Society of Toxicology"},{"issue":"4","key":"10.1016\/j.vascn.2021.107085_bb2000","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/1056-8719(94)90088-4","article-title":"Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates","volume":"32","author":"Hayes","year":"1994","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"6","key":"10.1016\/j.vascn.2021.107085_bb0050","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jelectrocard.2017.08.005","article-title":"Heart rate dependency of JT interval sections","volume":"50","author":"Hnatkova","year":"2017","journal-title":"Journal of Electrocardiology"},{"issue":"5","key":"10.1016\/j.vascn.2021.107085_bb0055","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.RES.64.5.977","article-title":"Early afterdepolarizations: Mechanism of induction and block. A role for L-type Ca2+ current","volume":"64","author":"January","year":"1989","journal-title":"Circulation Research"},{"issue":"5","key":"10.1016\/j.vascn.2021.107085_bb0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/clpt.2013.238","article-title":"Improving the assessment of heart toxicity for all new drugs through translational regulatory science","volume":"95","author":"Johannesen","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.vascn.2021.107085_bb0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/cpt.205","article-title":"Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial","volume":"99","author":"Johannesen","year":"2016","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/j.vascn.2021.107085_bb0070","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/clpt.2014.155","article-title":"Differentiating drug-induced multichannel block on the electrocardiogram: Randomized study of dofetilide, quinidine, ranolazine, and verapamil","volume":"96","author":"Johannesen","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"6","key":"10.1016\/j.vascn.2021.107085_bb0075","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clpt.2005.02.004","article-title":"A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data","volume":"77","author":"Jonker","year":"2005","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"7","key":"10.1016\/j.vascn.2021.107085_bb0080","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: Reporting in vivo experiments: The ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"7","key":"10.1016\/j.vascn.2021.107085_bb0085","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1476-5381.2010.00934.x","article-title":"The electro-mechanical window: A risk marker for Torsade de Pointes in a canine model of drug induced arrythmias","volume":"161","author":"van der Linde","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.vascn.2021.107085_bb0090","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.hrthm.2019.01.015","article-title":"Is the T(peak)-T(end) interval as a measure of repolarization heterogeneity dead or just seriously wounded?","volume":"16","author":"Malik","year":"2019","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.vascn.2021.107085_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.taap.2012.06.007","article-title":"The role of the anaesthetised guinea-pig in the preclinical cardiac safety evaluation of drug candidate compounds","volume":"263","author":"Marks","year":"2012","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107085_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vascn.2013.04.010","article-title":"The anesthetized guinea pig: An effective early cardiovascular derisking and lead optimization model","volume":"68","author":"Morissette","year":"2013","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2021.107085_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vascn.2015.05.007","article-title":"QT interval correction assessment in the anesthetized guinea pig","volume":"75","author":"Morissette","year":"2015","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2021.107085_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.vascn.2016.06.003","article-title":"Shortening of the electromechanical window in the ketamine\/xylazine-anaesthetized guinea pig model to assess pro-arrhythmic risk in early drug development","volume":"81","author":"Morrisette","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2021.107085_bb0115","series-title":"UK Animals Scientific Procedures Act","author":"National Archives","year":"1986"},{"key":"10.1016\/j.vascn.2021.107085_bb0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/1056-8719(92)90044-2","article-title":"Three-dimensional electrocardiography in the rat","volume":"27","author":"Rice","year":"1992","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"7083","key":"10.1016\/j.vascn.2021.107085_bb0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"HERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.vascn.2021.107085_bb0130","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13295","article-title":"Basal late sodium current is a significant contributor to the duration of action potential of guinea pig ventricular myocytes","volume":"5","author":"Song","year":"2017","journal-title":"Physiological Reports"},{"issue":"3","key":"10.1016\/j.vascn.2021.107085_bb0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jat.975","article-title":"QT prolongation in anaesthetized guinea-pigs: An experimental approach for preliminary screening of torsadogenicity of drugs and drug candidates","volume":"24","author":"Testai","year":"2004","journal-title":"Journal of Applied Toxicology"},{"issue":"4","key":"10.1016\/j.vascn.2021.107085_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001615","article-title":"Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil","volume":"4","author":"Vicente","year":"2015","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"10.1016\/j.vascn.2021.107085_bb0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cpt.896","article-title":"Mechanistic model-informed Proarrhythmic risk assessment of drugs: Review of the \u201cCiPA\u201d initiative and design of a prospective clinical validation study","volume":"103","author":"Vicente","year":"2018","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/j.vascn.2021.107085_bb0150","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cpt.1303","article-title":"Assessment of multi-ion channel block in a phase I randomized study design: Results of the CiPA phase I ECG biomarker validation study","volume":"105","author":"Vicente","year":"2019","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"7","key":"10.1016\/j.vascn.2021.107085_bb0155","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/bjp.2008.267","article-title":"Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model","volume":"154","author":"Yao","year":"2008","journal-title":"British Journal of Pharmacology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871921001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871921001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:04:40Z","timestamp":1761005080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871921001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":32,"alternative-id":["S1056871921001374"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2021.107085","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differentiating multichannel block on the guinea pig ECG: Use of Tpeak-Tend and J-Tpeak","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2021.107085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107085"}}